drugset / Trial / NCT06966674
No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to assess the no-reflow in patients with STEMI after intracoronary glycoprotein IIb/IIIa inhibitors after opening of track in thrombus.
Timeline
- Start
- 2025-05-12
- Primary completion
- 2025-10-01
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tirofiban | Other / unclassified | 25 mg/kg | Intravenous |